Red cell quinine concentrations in falciparum malaria

Area of Science:

• Pharmacokinetics
• Infectious Diseases
• Malariology

Background:

• Quinine is a primary antimalarial drug.
• Understanding drug distribution in red blood cells is vital for effective malaria treatment.
• Cerebral malaria presents unique challenges in drug efficacy.

Purpose of the Study:

• To compare red blood cell (RBC) and plasma quinine concentrations and elimination rates in patients with cerebral malaria and uncomplicated falciparum malaria.
• To investigate the relationship between RBC:plasma quinine ratio and parasite load.
• To assess the implications for drug resistance and treatment regimen design.

Main Methods:

• Measurement of quinine concentrations in red blood cells and plasma.
• Calculation of elimination half-times for both compartments.
• Analysis of the red cell:plasma concentration ratio over time.
• Correlation of the RBC:plasma ratio with blood parasite counts on admission.

Main Results:

• Red cell quinine elimination half-times were significantly shorter than plasma half-times in cerebral malaria and convalescent uncomplicated cases (P < 0.001).
• No significant difference in elimination half-times was observed in acute uncomplicated malaria (P = 0.12).
• The red cell:plasma quinine concentration ratio decreased progressively during treatment and was positively correlated with parasite count on admission (P = 0.02).

Conclusions:

• Red cell quinine concentrations and elimination kinetics differ significantly from plasma, particularly in severe malaria.
• RBC quinine levels may be a relevant marker for assessing antimalarial drug resistance.
• These findings can inform the design of more effective quinine treatment regimens for malaria.